Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou(Edinburgh Cancer Research), Simon P. Langdon(Edinburgh Cancer Research)
Cited by 107
Related Papers
Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of<i>in vitro</i>breast cancer models
|Oncotarget|2015|96
HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer
|Breast Cancer Research|2019|69
Sensitivity to pertuzumab (2C4) in ovarian cancer models: cross-talk with estrogen receptor signaling
|Molecular Cancer Therapeutics|2007|55
Defining the molecular response to trastuzumab, pertuzumab and combination therapy in ovarian cancer
|British Journal of Cancer|2012|49